News

GJE client TestCard win Pitch@Palace 12.0

GJE client, TestCard, have won the prestigious Pitch@Palace 12.0. The competition saw 38 entrepreneurs compete in front of an influential audience of potential supporters, including CEOs, influencers, angels, mentors and business partners. TestCard is an at-home urine test kit and accompanying mobile app that turns a phone’s camera into a clinical...

Read more

Brexit Update

At the moment, the UK is due to leave the EU on 31 January 2020 although it is possible that Brexit will happen earlier.  Whenever Brexit does happen there will be some changes to the status of EU trade mark and design rights but no rights will be lost. In...

Read more

GJE client OncoImmunity AS acquired by NEC Corporation

OncoImmunity AS has been acquired by renowned Japanese IT and network company, NEC Corporate. OncoImmunity AS develops software that identifies neoantigen targets for truly personalized cancer vaccines, cell therapies and optimal patient selection for cancer immunotherapy clinical trials. GJE provided OncoImmunity AS with IP-related due diligence support during the acquisition...

Read more

Financial Times recognises GJE as a leading European IP Firm with five Gold Awards

We are delighted to have been recognised as a leading European IP firm by the Financial Times. In addition, we have received five Gold Awards for our work in the following industry sectors: Chemistry & Pharmaceuticals, Electrical Engineering, IT & Software, Materials & Nanotechnology, and Mechanical Engineering; as well as a...

Read more

Fiona Stevens and Peter Finnie recognised by IAM Strategy 300 2019

We would like to congratulate Fiona Stevens and Peter Finnie for being recognised by the IAM Strategy 300: The World’s Leading IP Strategists. The unique guide lists the individuals that in-depth research has shown to possess world-class skills in the development and roll-out strategies that maximise the value of patents, copyright,...

Read more